Keybank National Association Infinity Pharmaceuticals, Inc. Transaction History

Keybank National Association

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 08, 2018	SELL	$1.72 - $2.26 $116,597 - $153,203	-67,789 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.8 - $2.74 $122,020 - $185,741	67,789 New	67,789 $142,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.